Kerry, the stalwart in the sector has signed a licensing partnership with Pharma Foods Pvt. Ltd. in order to develop a sustainable and highly progressive product range having all the essential health benefits paired with nutritional hotshots. Through this partnership a joint and integrated ingredient technology for range of functional foods ans healthy drinks and beverages.

Pharma Foods International, headquartered at Kyoto, Japan is a market leader all in all with rich expertise and innovative base for developing exemplary products that easily disrupts competition in the market.

This integration and licensing partnership deal is going to add up more in the products base and a gamut of innovation that company has developed post more than 10 years of age extensive research will prove to be highly beneficial to both the firms.

The ingredient promotes the natural production of hyaluronic acid, keeping joints lubricated and mobile and ultimately helping to reduce discomfort and stiffness in knee joints and providing benefit to people with osteoarthritis. As it is a water-soluble ingredient that has no impact to taste in formulation, it creates opportunities for functional food and beverage applications as well as dietary supplements. The ingredient has already been formulated into several products in the Japanese market and the company will be developing a brand positioning for the technology, supporting application and development and supplying the ingredient to customers across the world.

John Quilter, vice president and general manager for Kerry’s ProActive Health business, said, “Our proprietary consumer research has revealed that consumers want healthy lifestyle products that also have a positive impact on bone and joint health. Today’s consumers are more informed about the ingredients in their functional products – with 56 per cent reporting that they regularly research ingredients that can help improve health. We are delighted to partner with PFI, a leader in functional ingredient innovation, on this new joint health technology which will complement our portfolio of science-backed branded ingredients, including GanedenBC30 probiotic, Wellmune yeast beta glucan, and our most recent addition, Bio-K Plus probiotics.”

Dr Mujo Kim, chief executive officer of Pharma Foods International, said, “We are very pleased and excited to be working with Kerry. PFI has been researching and developing original unique materials for the global market and now that we have established a cooperative relationship with Kerry, we will be able to accelerate our global expansion. We expect strong synergies between PFI’s research capabilities and Kerry’s global commercial network.”


A Zoophile scrambling the horizon for surreal subtleties, sheer poetic at heart and quite handy with life.

Write A Comment